186 related articles for article (PubMed ID: 26706102)
21. Synthesis and in vitro cytotoxicity of novel lipophilic (diamine)platinum(II) complexes of salicylate derivatives.
Ye QS; Lou LG; Liu WP; Yu Y; Chen XZ; Hou SQ; Gao WQ; Liu Y
Bioorg Med Chem Lett; 2007 Apr; 17(8):2146-9. PubMed ID: 17306532
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, biological evaluation and SAR studies of novel bicyclic antitumor platinum(IV) complexes.
Lorenzo J; Delgado A; Montaña ÁM; Mesas JM; Alegre MT; Rodríguez Mdel C; Avilés FX
Eur J Med Chem; 2014 Aug; 83():374-88. PubMed ID: 24980119
[TBL] [Abstract][Full Text] [Related]
23. Vitamin B₁₂ as a carrier for targeted platinum delivery: in vitro cytotoxicity and mechanistic studies.
Ruiz-Sánchez P; König C; Ferrari S; Alberto R
J Biol Inorg Chem; 2011 Jan; 16(1):33-44. PubMed ID: 20803225
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
[TBL] [Abstract][Full Text] [Related]
25. Study on Antitumor Platinum(II) Complexes of Chiral Diamines with Dicyclic Species as Steric Hindrance.
Liu F; Gou S; Chen F; Fang L; Zhao J
J Med Chem; 2015 Aug; 58(16):6368-77. PubMed ID: 26247573
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and anticancer activity of [2-hydroxy-1,3-diaminopropane-kappa 2N,N'] platinum(II) complexes.
Liu W; Chen X; Xie M; Lou L; Ye Q; Yu Y; Hou S
J Inorg Biochem; 2008 Oct; 102(10):1942-6. PubMed ID: 18707762
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, biodistribution and antitumor activity of hematoporphyrin-platinum(II) conjugates.
Kim YS; Song R; Hyun Kim D; Jun MJ; Sohn YS
Bioorg Med Chem; 2003 Apr; 11(8):1753-60. PubMed ID: 12659761
[TBL] [Abstract][Full Text] [Related]
28. Potent anticancer activity and possible low toxicity of platinum(II) complexes with functionalized 1,1-cyclobutanedicarboxylate as a leaving ligand.
Zhao J; Gou S; Liu F
Chemistry; 2014 Nov; 20(46):15216-25. PubMed ID: 25256173
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and cytotoxicity of enantiomerically pure [1,2-diamino-1-(4-fluorophenyl)-3-methylbutane]platinum(II) complexes.
Dullin A; Dufrasne F; Gelbcke M; Gust R
ChemMedChem; 2006 Jun; 1(6):644-53. PubMed ID: 16892405
[TBL] [Abstract][Full Text] [Related]
30. Cytotoxicity of cis-platinum(II) conjugate models. The effect of chelating arms and leaving groups on cytotoxicity: a quantitative structure-activity relationship approach.
Monti E; Gariboldi M; Maiocchi A; Marengo E; Cassino C; Gabano E; Osella D
J Med Chem; 2005 Feb; 48(3):857-66. PubMed ID: 15689170
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and biological evaluation of a novel series of glycosylated platinum(iv) complexes as antitumor agents.
Wang Q; Huang Z; Ma J; Lu X; Zhang L; Wang X; George Wang P
Dalton Trans; 2016 Jun; 45(25):10366-74. PubMed ID: 27252024
[TBL] [Abstract][Full Text] [Related]
32. In vitro biological evaluation of platinum(II) complexes with 1-(methoxy substituted benzyl) azetidine-3,3-dicarboxylato ligands.
Yin R; Gou S; Sun Y; Liu X
Bioorg Med Chem; 2012 Feb; 20(4):1461-7. PubMed ID: 22264764
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and hydrolysis studies of novel glyco-functionalized platinum complexes.
Möker J; Thiem J
Carbohydr Res; 2012 Feb; 348():14-26. PubMed ID: 22196927
[TBL] [Abstract][Full Text] [Related]
34. Design, modeling, synthesis and biological activity evaluation of camptothecin-linked platinum anticancer agents.
Cincinelli R; Musso L; Dallavalle S; Artali R; Tinelli S; Colangelo D; Zunino F; De Cesare M; Beretta GL; Zaffaroni N
Eur J Med Chem; 2013 May; 63():387-400. PubMed ID: 23517728
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, characterization, and in vitro antitumor activity of osteotropic diam(m)ineplatinum(II) complexes bearing a N,N-bis(phosphonomethyl)glycine ligand.
Galanski MS; Slaby S; Jakupec MA; Keppler BK
J Med Chem; 2003 Nov; 46(23):4946-51. PubMed ID: 14584945
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, characterization and biological evaluation of platinum(II) complexes with a chiral N-monosubstituted 1,2-cyclohexyldiamine derivative.
Gao C; Gou S; Xu G
Chem Pharm Bull (Tokyo); 2011; 59(7):851-4. PubMed ID: 21720035
[TBL] [Abstract][Full Text] [Related]
37. Platinum(II) complexes containing long-chain hydrophobic N-alkyl-diamine ligands: synthesis, characterization, molecular modeling, and cytotoxic activity.
Tavares TT; Teixeira GF; Lopes CM; Novato WT; Silva H; Lopes MT; De Almeida MV; Grazul RM; Dos Santos HF; Fontes AP
J Inorg Biochem; 2012 Oct; 115():13-9. PubMed ID: 22922288
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and structure-activity relationship of novel antitumoral platinum xanthate complexes.
Friebolin W; Schilling G; Zöller M; Amtmann E
J Med Chem; 2004 Apr; 47(9):2256-63. PubMed ID: 15084124
[TBL] [Abstract][Full Text] [Related]
39. Platinum(II) complexes with l-methionylglycine and l-methionyl-l-leucine ligands: synthesis, characterization and in vitro antitumoral activity.
Kaluderović GN; Schmidt H; Paschke R; Kalinowski B; Dietrich A; Mueller T; Steinborn D
J Inorg Biochem; 2007 Mar; 101(3):543-9. PubMed ID: 17223197
[TBL] [Abstract][Full Text] [Related]
40. Robust structure and reactivity of aqueous arsenous acid-platinum(II) anticancer complexes.
Miodragović ĐU; Quentzel JA; Kurutz JW; Stern CL; Ahn RW; Kandela I; Mazar A; O'Halloran TV
Angew Chem Int Ed Engl; 2013 Oct; 52(41):10749-52. PubMed ID: 24038962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
